Hemangiosarcoma in dogs — the rupture event most owners do not see coming

The short answer

Hemangiosarcoma is the second most common life-ending cancer in older dogs. Its hallmark is the silent course followed by sudden collapse. Owners arrive at the decision point with a dog who looks well; the cancer’s biology means the apparent wellness is the hardest part of the choice.

What it is

A cancer that arises from the vascular endothelium — the cells that line blood vessels. Because vessels are everywhere in the body, hemangiosarcoma can develop in many sites. The most common are:

• Splenic (most common; ~50% of cases)
• Right atrial / cardiac (~25%)
• Cutaneous / subcutaneous (skin; better prognosis when caught early)
• Hepatic, retroperitoneal, bone (less common)

Breeds at risk

German Shepherds, Golden Retrievers, Labradors, Boxers, Doberman Pinschers, and large mixed breeds carry the highest risk. Goldens, in some studies, have a lifetime hemangiosarcoma incidence approaching 20%. See golden retriever cancer life expectancy.

How it presents

Three patterns:

1. Sudden collapse. The most dramatic — the dog was well in the morning, collapses by evening, gums are pale or grey, breathing is rapid. Cause: a splenic or cardiac tumour has ruptured and the dog is bleeding into the abdomen or pericardium. Emergency vet visit is required immediately.
2. Episodic weakness. Periods of lethargy lasting hours, followed by apparent recovery. Each episode is a small bleed that resolves; the cumulative trajectory is downward. Owners often dismiss the first one or two episodes; by the third, the diagnosis is usually clear.
3. Incidental finding. A mass detected during routine ultrasound or imaging for an unrelated complaint. The dog may have no clinical signs at all.

Survival numbers, honestly

The decision frame:

• No treatment after splenic rupture: days to two weeks.
• Splenectomy alone: 1–3 months median.
• Splenectomy + doxorubicin chemotherapy: 4–6 months median.
• Cardiac variant, surgery + chemo: shorter; 3–4 months median.
• Cutaneous, fully excised, low-grade: potentially curative.

These are medians. Half of dogs do better; half worse. A 16-month survival is uncommon but possible; a 6-week survival despite treatment is also possible. See life expectancy by canine cancer type for context.

The decision points

Three forks:

1. Splenectomy or not. If the dog has had a rupture, splenectomy is often life-saving in the immediate term. If the diagnosis is incidental and there is no rupture, splenectomy is still usually recommended because it removes the rupture risk and provides histological diagnosis. The exception: a dog with significant comorbidities for whom anaesthesia carries unusual risk.
2. Chemotherapy or not. Doxorubicin is the standard. The protocol is 4–5 cycles every 3 weeks. Side effects in dogs are usually modest. The benefit is real but bounded — months, not years. Cost in India: ₹50,000–1,00,000 for the protocol.
3. Pre-emptive euthanasia vs waiting. Some owners, faced with an inoperable cardiac variant or a refusal of surgery, elect euthanasia at the first significant deterioration rather than wait for a rupture event that could occur at any time. Both are defensible.

The rupture conversation

The most important conversation to have with your vet, in advance:

• What does a rupture look like? (Sudden collapse, pale gums, abdominal distension, weakness.)
• Where is the closest 24-hour clinic to my home?
• Do I want my dog to be transported and resuscitated, or do I want home-based comfort care if a rupture occurs?
• If transported, do I want surgical re-stabilisation, or only humane euthanasia at that point?

Owners who decide these questions in advance describe the rupture event as still distressing but not chaotic. Owners who have not had the conversation describe panic, confusion, and post-hoc regret about decisions made under acute stress.

Editorial reference, not veterinary advice. — Dr. NRS, last reviewed 28 April 2026.